Follow
Christopher J. Draper-Joyce
Christopher J. Draper-Joyce
The Florey Institute, The University of Melbourne
Verified email at florey.edu.au - Homepage
Title
Cited by
Cited by
Year
Structure of the adenosine-bound human adenosine A1 receptor–Gi complex
CJ Draper-Joyce, M Khoshouei, DM Thal, YL Liang, ATN Nguyen, ...
Nature 558 (7711), 559-563, 2018
3212018
A new mechanism of allostery in a G protein–coupled receptor dimer
JR Lane, P Donthamsetti, J Shonberg, CJ Draper-Joyce, S Dentry, ...
Nature chemical biology 10 (9), 745-752, 2014
1252014
Rules of engagement: GPCRs and G proteins
A Glukhova, CJ Draper-Joyce, RK Sunahara, A Christopoulos, D Wootten, ...
ACS pharmacology & translational science 1 (2), 73-83, 2018
1132018
Positive allosteric mechanisms of adenosine A1 receptor-mediated analgesia
CJ Draper-Joyce, R Bhola, J Wang, A Bhattarai, ATN Nguyen, ...
Nature 597 (7877), 571-576, 2021
932021
Dominant negative G proteins enhance formation and purification of agonist-GPCR-G protein complexes for structure determination
YL Liang, P Zhao, C Draper-Joyce, JA Baltos, A Glukhova, TT Truong, ...
ACS pharmacology & translational science 1 (1), 12-20, 2018
932018
Recent advances in the determination of G protein-coupled receptor structures
DM Thal, Z Vuckovic, CJ Draper-Joyce, YL Liang, A Glukhova, ...
Current opinion in structural biology 51, 28-34, 2018
632018
Discovery of a Novel Class of Negative Allosteric Modulator of the Dopamine D2 Receptor Through Fragmentation of a Bitopic Ligand
SN Mistry, J Shonberg, CJ Draper-Joyce, C Klein Herenbrink, M Michino, ...
Journal of medicinal chemistry 58 (17), 6819-6843, 2015
542015
Structure–Activity Study of N-((trans)-4-(2-(7-Cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a Bitopic Ligand That Acts as a …
J Shonberg, C Draper-Joyce, SN Mistry, A Christopoulos, PJ Scammells, ...
Journal of Medicinal Chemistry 58 (13), 5287-5307, 2015
452015
The structural determinants of the bitopic binding mode of a negative allosteric modulator of the dopamine D2 receptor
CJ Draper-Joyce, M Michino, RK Verma, CK Herenbrink, J Shonberg, ...
Biochemical pharmacology 148, 315-328, 2018
282018
Molecular determinants of the intrinsic efficacy of the antipsychotic aripiprazole
C Klein Herenbrink, R Verma, HD Lim, A Kopinathan, A Keen, J Shonberg, ...
ACS chemical biology 14 (8), 1780-1792, 2019
242019
Conformational Transitions and the Activation of Heterotrimeric G Proteins by G Protein-Coupled Receptors
C Draper-Joyce, SGB Furness
ACS Pharmacology & Translational Science 2 (4), 285-290, 2019
172019
Subtle Modifications to the Indole-2-carboxamide Motif of the Negative Allosteric Modulator N-((trans)-4-(2-(7-Cyano-3, 4-dihydroisoquinolin-2 (1 H)-yl) ethyl) cyclohexyl)-1 H …
A Kopinathan, C Draper-Joyce, M Szabo, A Christopoulos, PJ Scammells, ...
Journal of Medicinal Chemistry 62 (1), 371-377, 2018
172018
The action of a negative allosteric modulator at the dopamine D2 receptor is dependent upon sodium ions
CJ Draper-Joyce, RK Verma, M Michino, J Shonberg, A Kopinathan, ...
Scientific Reports 8 (1), 1208, 2018
162018
Structural insights into the unique modes of relaxin-binding and tethered-agonist mediated activation of RXFP1 and RXFP2
A Sethi, S Bruell, T Ryan, F Yan, MH Tanipour, YF Mok, C Draper-Joyce, ...
Journal of Molecular Biology 433 (21), 167217, 2021
72021
Positive allosteric modulation of a GPCR ternary complex
W Burger, C Draper-Joyce, C Valant, A Christopoulos, DM Thal
bioRxiv, 2024.04. 04.588200, 2024
2024
Strength in numbers—an arrestin interaction code
CJ Draper-Joyce, A Christopoulos
Nature Structural & Molecular Biology 25 (6), 437-439, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–16